Oseltamivir Phosphate for Oral Suspension (Alvogen Inc.)
Welcome to the PulseAid listing for the Oseltamivir Phosphate for Oral Suspension drug offered from Alvogen Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alvogen Inc. |
| NON-PROPRIETARY NAME: | Oseltamivir Phosphate |
| SUBSTANCE NAME: | OSELTAMIVIR PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | POWDER, FOR SUSPENSION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-11-01 |
| END MARKETING DATE: | 0000-00-00 |
Oseltamivir Phosphate for Oral Suspension HUMAN PRESCRIPTION DRUG Details:
| Item Description | Oseltamivir Phosphate for Oral Suspension from Alvogen Inc. |
| LABELER NAME: | Alvogen Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6(mg/mL) |
| START MARKETING DATE: | 2017-11-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47781-384_a79fc56c-af33-1709-6345-0a0c6e2d7883 |
| PRODUCT NDC: | 47781-384 |
| APPLICATION NUMBER: | ANDA208823 |
Other OSELTAMIVIR PHOSPHATE Pharmaceutical Manufacturers / Labelers:
